Regulatory EMA seeks input on virtual alternative to animal test PharmaphorumEMA delivers a milestone in the replacement of animals in drug testing with the qualification of a virtual model for repeat-dose toxicity studies.RegulatoryRead full story pharminent April 1, 2026 (Last updated: April 1, 2026) Pharmaphorum EMA delivers a milestone in the replacement of animals in drug testing with the qualification of a virtual model for repeat-dose toxicity studies. RegulatoryRead full story Post navigation Previous: Novo Sheds 400 at Embattled Manufacturing SiteNext: IO Shuts Down Following Regulatory Roadblocks Related Stories Regulatory Third Circuit Affirms Denial of Stelara Biosimilar Injunction pharminent May 11, 2026 Regulatory Partner’s Bizengri cleared by FDA for ultra-rare cancer days after winning priority voucher pharminent May 11, 2026 Regulatory BMS’ Sotyktu secures EC approval for psoriatic arthritis pharminent May 11, 2026
